UBS ASSET MANAGEMENT AMERICAS INC - MOLECULAR TEMPLATES INC ownership

MOLECULAR TEMPLATES INC's ticker is MTEM and the CUSIP is 608550109. A total of 88 filers reported holding MOLECULAR TEMPLATES INC in Q3 2021. The put-call ratio across all filers is 1.16 and the average weighting 0.2%.

Quarter-by-quarter ownership
UBS ASSET MANAGEMENT AMERICAS INC ownership history of MOLECULAR TEMPLATES INC
ValueSharesWeighting
Q3 2021$188,698,000
-14.2%
28,1220.0%0.00%
Q2 2021$219,914,000
+55.6%
28,122
+151.1%
0.00%
Q1 2021$141,344,000
-32.5%
11,200
-49.8%
0.00%
Q4 2020$209,397,000
+72.8%
22,300
+100.9%
0.00%
Q3 2020$121,212,000
-13.8%
11,100
+8.8%
0.00%
Q2 2020$140,658,00010,2000.00%
Other shareholders
MOLECULAR TEMPLATES INC shareholders Q3 2021
NameSharesValueWeighting ↓
CAXTON CORP 2,137,991$8,381,0006.85%
ACUTA CAPITAL PARTNERS, LLC 322,500$1,264,0000.53%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,021,317$4,004,0000.46%
BVF INC/IL 3,129,599$12,268,0000.44%
Bellevue Group AG 10,878,003$42,642,0000.44%
FRAZIER MANAGEMENT LLC 1,374,047$5,386,0000.42%
Endurant Capital Management LP 268,375$1,052,0000.25%
Abingworth LLP 200,000$780,0000.19%
Parkman Healthcare Partners LLC 147,728$579,0000.13%
GSA CAPITAL PARTNERS LLP 145,329$570,0000.07%
View complete list of MOLECULAR TEMPLATES INC shareholders